Weightless a doctor's guide to GLP-1 medications, sustainable weight loss, and the health you deserve

"A board-certified endocrinologist [discusses] using GLP-1 medications such as Ozempic, Wegovy, Mounjaro, and Zepbound to reverse obesity and take charge of your health, with established strategies formaximizing your results"--

Saved in:
Bibliographic Details
Main Author: Salas-Whalen, Rocio (Author)
Other Authors: Haver, Mary Claire (writer of foreword.)
Format: Books Print Book
Language:English
Published: New York : Rodale, [2025]
Edition:First edition.
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000cam a22000001i 4500
001 on1564038043
003 OCoLC
005 20260119145100.0
008 251216s2025 nyua b 001 0 eng d
019 |a 1528852052 
020 |a 9780593981207  |q (hardback) 
020 |a 0593981200  |q (hardcover) 
035 |a (OCoLC)1564038043  |z (OCoLC)1528852052 
040 |a IG#  |b eng  |e rda  |c IG#  |d OCLCO  |d BDX  |d OCO 
050 4 |a RM222.2  |b .S2243 2025 
082 0 4 |a 613.2/5  |2 23/eng/20251216 
100 1 |a Salas-Whalen, Rocio,  |e author. 
245 1 0 |a Weightless :  |b a doctor's guide to GLP-1 medications, sustainable weight loss, and the health you deserve /  |c Rocio Salas-Whalen ; foreword by Mary Claire Haver. 
250 |a First edition. 
264 1 |a New York :  |b Rodale,  |c [2025] 
300 |a xviii, 263 pages :  |b illustrations ;  |c 25 cm 
336 |a text  |b txt  |2 rdacontent 
337 |a unmediated  |b n  |2 rdamedia 
338 |a volume  |b nc  |2 rdacarrier 
504 |a Includes bibliographical references and index. 
520 |a "A board-certified endocrinologist [discusses] using GLP-1 medications such as Ozempic, Wegovy, Mounjaro, and Zepbound to reverse obesity and take charge of your health, with established strategies formaximizing your results"--  |c From publisher marketing. 
520 |a Examines the role of GLP-1 medications in the medical treatment of obesity and addresses common misconceptions surrounding their use. Drawing on clinical experience, endocrinologist Dr. Rocio Salas-Whalen outlines evidence-based strategies for weight management, emphasizing the importance of proper medical supervision. The work frames obesity as a chronic health condition rather than a personal failing and presents a patient-centered approach to long-term care and health outcomes. 
650 0 |a Glucagon-like peptide 1  |x Agonists  |x Therapeutic use. 
650 0 |a Appetite depressants. 
650 0 |a Obesity  |x Treatment. 
650 0 |a Weight loss. 
650 0 |a Reducing diets. 
655 7 |a Self-help publications.  |2 lcgft 
700 1 |a Haver, Mary Claire,  |e writer of foreword. 
994 |a C0  |b PCB 
949 |a schlow  |b SANONNE  |c 613.25 SAL  |d i  |e 39635104828315  |f 808363  |g ddc  |j 11/11/2025 
999 |a 513696